Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases

Sanjeev Noel1, Abdel R A Hamad2, Hamid Rabb1

  • 1Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Kidney International
|December 10, 2015
PubMed

Insights

The transcription factor Nrf2 is crucial for kidney health and disease. This study reveals new Nrf2 targets in mouse kidneys, aiding the development of treatments for kidney disorders.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genomics

Background:

  • The transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2) is a key regulator of cellular defense against oxidative stress.
  • Nrf2 activation is implicated in various kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD).
  • Preliminary Nrf2-targeting therapies have shown promise in human clinical trials for kidney conditions.

Purpose of the Study:

  • To conduct an integrated transcriptomic and proteomic analysis of mouse kidney tissue.
  • To identify novel Nrf2 target genes and proteins involved in kidney function and disease.
  • To deepen the understanding of Nrf2-mediated pathways in renal homeostasis and pathophysiology.

Main Methods:

  • Utilized transcriptomic analysis to assess gene expression profiles in mouse kidneys.
  • Employed proteomic analysis to quantify protein levels and identify Nrf2-regulated proteins.
  • Integrated data from both transcriptomic and proteomic analyses to identify key Nrf2 targets.

Main Results:

  • Identified a comprehensive set of Nrf2 target genes and proteins in the mouse kidney.
  • Revealed specific molecular pathways regulated by Nrf2 that are critical for kidney homeostasis.
  • Uncovered potential Nrf2-dependent mechanisms contributing to kidney pathophysiology.

Conclusions:

  • The findings provide a detailed map of Nrf2 targets in the kidney.
  • This research enhances our understanding of Nrf2's role in kidney health and disease.
  • The identified targets offer potential avenues for developing novel Nrf2-based therapeutics for a spectrum of kidney diseases.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
575
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
482
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
8.7K